S.THEPHARM

S.THEPHARM Co., Ltd., established in 2016, is a leading South Korean company specializing in bio-beauty and aesthetic products. As a subsidiary of S.Biomedics, which excels in stem cell therapy technology, S.THEPHARM is dedicated to developing high-quality anti-aging and cosmetic surgery products. The company's product portfolio includes QTFILL PLUS, a monophasic hyaluronic acid filler with lidocaine, and QTCell, a cosmeceutical line featuring human dermal fibroblast-conditioned media rich in growth factors for skin regeneration and wrinkle improvement. S.THEPHARM's products are renowned for their safety and effectiveness, achieved through advanced proprietary technologies such as Ultra High Density (UHD) technology. This method ensures high viscoelasticity with reduced BDDE content, enhancing the safety profile of their fillers. The company's commitment to quality is evidenced by its ISO 13485 and GMP certifications. With a robust R&D team and a focus on customer satisfaction, S.THEPHARM continues to lead the market with innovative solutions in aesthetic medicine and cosmetic surgery​